Stereotaxis CEO to Present at the 12th Annual BIOMEDevice San Jose Conference
BIOMEDevice San Jose is a two-day educational program focused on the expansion of digital technology in the field of healthcare, gathering top medical device innovators, experts, and physicians to discuss the role of digital medicine in revolutionizing the healthcare industry. It will take place at the
“We are excited to join BIOMEDevice to explore the future of robotic surgery and the role our technology can play in positively transforming interventional medicine. I am honored to participate in this program alongside many industry experts and innovators and look forward to being part of the event,” Mr. Fischel said.
BIOMEDevice San Jose is a must-attend event for medtech professionals looking to learn, share, and discuss significant trends, latest developments, and key technologies that are moving the medtech industry forward. The program will highlight sectors ranging from digital health to in vitro diagnostics and delve into cutting-edge technologies that are revolutionizing medical devices. The program will also focus on the latest in minimally invasive surgery and the expansion of surgical robotics.
This press release includes statements that may constitute "forward-looking" statements usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness, or to obtain additional financing, in either case on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from healthcare reform in
Chairman and Chief Executive Officer
Kimberly R. Peery
Chief Financial Officer
Source: Stereotaxis, Inc.